As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%

2022 was a big year for layoffs in biopharma. So were the next three. Novartis, for instance, outlined plans to cut up to 8,000 jobs in 2022, after pharmaceutical industry job cuts jumped 280% in 2021. Biogen followed in 2023 with a “Fit for Growth” program that put roughly 1,000 roles on the block. Bristol… The post As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%…